Hemoglobin A, Glycosylated - Analysis
Research News and Information

Saturday, November 21, 2009

Improving chronic care of type 2 diabetes using teams of interprofessional learners.

30 Oct 2009 PURPOSE: To improve the care and outcomes of adult patients with type 2 diabetes by teaching interprofessional teams of learners the principles and practices of the Improving Chronic Illness Care Model. METHOD: The study population consisted of 384 ... Read more...

Early progression of the autonomic dysfunction observed in pediatric type 1 diabetes mellitus.

3 Oct 2009 To focus on early cardiac and vascular autonomic dysfunction that might complicate type 1 diabetes mellitus in children, we planned an observational, cross-sectional study in a population of 93 young patients, under insulin treatment, subdivided in ... Read more...

A case of discordant HbA(1c): a method-dependent error.

19 Sep 2009 Although glycated haemoglobin (HbA(1c)) has become the key biochemical marker of long-term glycaemic control, analytical method-dependent differences in results can occur when haemoglobin variants are present or HbA(1c) is reduced by decreased red ... Read more...

Latest indexed articles for 'Hemoglobin A, Glycosylated - Analysis'

These are the very latest articles for this heading:

• Improving chronic care of type 2 diabetes using teams of interprofessional learners. 30 Oct 2009
• Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. 10 Oct 2009
• Early progression of the autonomic dysfunction observed in pediatric type 1 diabetes mellitus. 3 Oct 2009
• A case of discordant HbA(1c): a method-dependent error. 19 Sep 2009
• Controlling the complications of diabetes: it's about the sugar. 13 Sep 2009
• Blindness in a 25-year follow-up of a population-based cohort of Danish type 1 diabetic patients. 8 Sep 2009
• Quality of care of diabetes mellitus type II patients in Iran. 30 Aug 2009
• [Prevalence of pancreatic cancer in diabetics and clinical characteristics of diabetes-associated with pancreatic cancer--comparison between diabetes with and without pancreatic cancer] 30 Aug 2009
• The effects of a commercially available weight loss program among obese patients with type 2 diabetes: a randomized study. 30 Aug 2009
• Defining the importance of daily glycemic control and implications for type 2 diabetes management. 30 Aug 2009
• The effects of an incentive program on quality of care in diabetes management. 30 Aug 2009
• Diabetes study findings: what do they mean? 30 Aug 2009
• [Intensive glucose control in type 2 diabetes is beneficial] 30 Aug 2009
• Medical certification for pilots of commercial suborbital spaceflights. 30 Aug 2009
• Are we meeting the American Diabetes Association goals for HIV-infected patients with diabetes mellitus? 30 Aug 2009
• Tracking diabetes: New York City's A1C Registry. 30 Aug 2009
• The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. 30 Aug 2009
• Effect of the method to measure levels of glycated hemoglobin on individual clinical decisions: comparison of an immunoassay with high-performance liquid chromatography. 30 Aug 2009
• Efficacy and safety of two 5 day insulin dosing regimens to achieve strict glycaemic control in patients with acute ischaemic stroke. 30 Aug 2009
• Significance of inflammatory markers in diabetic patients with stable coronary artery disease. 24 Aug 2009

See a longer list of these articles.

Technical information about 'Hemoglobin A, Glycosylated'

Definition: Minor hemoglobin components of human erythrocytes designated A1a, A1b, and A1c. Hemoglobin A1c is most important since its sugar moiety is glucose covalently bound to the terminal amino acid of the beta chain. Since normal glycohemoglobin concentrations exclude marked blood glucose fluctuations over the preceding three to four weeks, the concentration of glycosylated hemoglobin A is a more reliable index of the blood sugar average over a long period of time.

Registry Number: 0

Descriptor UI: D006442

Alternative terms: Hemoglobin A, Glycosylated; Hb A1a+b; Hb A1c; HbA1; Glycosylated Hemoglobin A; Hb A1; Glycohemoglobin A; Hemoglobin A(1); Hemoglobin, Glycosylated A1b; A1b Hemoglobin, Glycosylated; Glycosylated A1b Hemoglobin; Hb A1b; Hemoglobin, Glycosylated A1a-1; A1a-1 Hemoglobin, Glycosylated; Glycosylated A1a-1 Hemoglobin; Hemoglobin, Glycosylated A1a 1; Hb A1a-1; Hb A1a-2; Hemoglobin, Glycosylated; Glycosylated Hemoglobin; Glycated Hemoglobins; Hemoglobins, Glycated;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D09.408.375; D12.776.124.400.405.440; D12.776.422.316.762.380.440;

History Note: 82

Technical Notes: urine: coord IM with HEMOGLOBINURIA (IM); DF: note short X refs